golodirsen: Clinical Trials

1 trial of golodirsen, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 terminated. 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 41Terminated 1

Follow golodirsen: new trials by email Literature Review of golodirsen trials Research Report on golodirsen

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
An Open-Label Study of Golodirsen in Non-Ambulant Patients With Duchenne Muscular Dystrophy
Golodirsen 50 MG/1 ML Intravenous Solution [VYONDYS 53] - Duchenne Muscular Dystrophy
Phase 4TerminatedRare Disease Research, LLC22020-10-312026-04-03

Conditions studied

Muscular Dystrophy, Duchenne (1)

Sponsors

Rare Disease Research, LLC (1)

Countries

United States (1)